General procedure for deacetylation
The per-O-acetylated glycoside was dissolved in dry MeOH (1-2 ml MeOH per 10 mg sugar) and cooled to 0°C. Sodium methoxide in MeOH (380 mM) was added drop-wise to give a final concentration of 20 mM. The reaction was stirred at r.t. Upon completion (as determined by TLC), the reaction was neutralized with acid resin (Amberlite ® (C=O (Ar) ).
9H-(1,3-Dichloro-9,9-dimethylacridin-7-on-2-yl) 2-deoxy-2-fluoro-β-D-glucopyranoside (DDAO-2FGlc) (1)
Compound 8 (53 mg, 0.089 mmol) was treated according to the general procedure for deacetylation.
The crude product was purified by flash chromatography (EtOAc/hexanes, 3:2-4:1) to give polyol 1 as (Me 2 CO/Et 2 O/hexanes) to give galactoside 11 as yellow needles (130 mg, 18% 
Compound 11 (93 mg, 0.15 mmol) was treated according to the general procedure for deacetylation.
The crude product was purified by flash chromatography (EtOAc/hexanes, 4:1) to give polyol 2 as a yellow powder (61 mg, 84% 187.39 (C=O (Ar) ).
Compound 13 (88 mg, 0.17 mmol) was treated according to the general procedure for deacetylation.
The crude product was purified by flash chromatography (EtOAc/hexanes, 4:1) to give polyol 3 as a yellow powder (78 mg, 99% 
Per-O-acetyl cellobial 8 14 (6.7 g, 12 mmol) and Selectfluor ® (6.0 g, 18 mmol, 1.5 eqv.) were dissolved in MeNO 2 (100 ml) and water (20 ml). The reaction was warmed to ambient temperature and stirred for 72 h. The mixture was diluted with EtOAc and washed with sat. NaHCO 3 followed by brine. The organic layer was dried with anhydrous MgSO 4 , filtered and the solvent evaporated under reduced pressure. The mixture (4 g) was dissolved in pyridine (25 ml) and Ac 2 O (120 ml) and stirred at r. 
Compound 16 (40 mg, 0.46 mmol) was treated according to the general procedure for deacetylation.
The crude product was recrystallized (MeOH) to give polyol 4 as a yellow powder (15 mg, 53% 
Kinetic analyses
Enzyme kinetic experiments were performed as described below using the conditions outlined in Table   S1 . Extinction coefficients for all aglycones, except those for DDAO, were obtained from Kempton and Withers. 10 All experiments were performed in buffer with DMSO content (v/v) not exceeding 5%. 
General procedure for indirect inactivation assays
Varying concentrations of the inactivator compound were incubated with enzyme in the buffer and at the temperature listed in Table S1 . At appropriate time-points, aliquots of this enzyme-inactivator reaction mixture were removed and diluted into a cuvette containing the appropriate substrate at a high concentration (7-15 × K m ) that had been pre-incubated under the same buffer and temperature conditions ( Table S1 ), such that the final volume was 200 µl. The residual intial rate of substrate hydrolysis for each time-point was determined by monitoring the change in absorbance of the sample at an appropriate wavelength with respect to time. Each time point was plotted against its rate and the data set then fit to a pseudo-first order decay equation to obtain the rate constant of inactivation (k obs ) at that inactivator concentration. The resulting k obs values were plotted against the corresponding inactivator concentration and fit to Equations 1 or 2 to obtain the kinetic parameters k i and K i .
Equation 1:
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General procedure for direct inactivation assays
Varying concentrations of the inactivator were pre-incubated in the buffer and at the temperature listed in Table S1 . The inactivation reaction was initiated by the addition of enzyme. DDAO release was monitored continuously by observing the solutions' absorbance at 600 nm. The inactivation parameters (k i and K i ) were obtained either by fitting the initial rates of inactivation, or the observed rate constants of inactivation (k obs ), to a Michaelis-Menten type equation (Equation 1). For the latter, the k obs values were obtained by fitting the derivative of the absorbance vs. time plots to an exponential decay curve using GraFit 7.0.
General procedure for direct inactivation assays by stopped flow
Experiments were performed on an Applied Photophysics SX20 stopped flow machine coupled with a water bath. Two syringes were filled with 800 µl of 0.64 µM Abg or inactivator 1 (2.58 µM to 137 µM) and incubated at 37°C for 5 minutes. DDAO release was monitored by absorbance at 600 nm, and the resulting curves were averaged and fit with the accompanying software (Pro-Data SX Viewer) using an pK a Determinations pK a determinations for DDAO were performed in buffer containing 50 mM citrate, 50 mM sodium phosphate and 50 mM Tris. Buffer pH was adjusted using NaOH or HCl. Solutions (1000 µl) of DDAO (2 µM) were incubated at 37°C for 5 min. The fluorescence response at 600 V was recorded and plotted as a function of pH. This data set was fit to a pH titration curve using GraFit 5.0.
Extinction coefficient determinations
DDAO (11-15 mg) was dissolved in DMSO (1.0 ml), diluted 100-fold into DMSO, then further diluted 20-fold into 50 mM sodium phosphate buffer (pH 6.8) to give a final concentration of 17-24 µM DDAO. Further dilutions into buffer were made (10, 20, 50 and 100-fold) and, after equilibration at 37°C for 5 min, their absorbance at 600 nm were measured. These values were plotted as a function of DDAO concentration to give a good linear correlation (R 2 > 0.97 in all cases). The final extinction coefficient value was determined using Beer's law and is an average of seven independent replicates.
Active site titrations of Abg
Solutions of Abg in sodium phosphate buffer at pH 6.8 were equilibrated at 37°C for 5 min. A baseline absorbance (600 nm) or fluorescence (λ ex = 600 nm, λ em = 656 nm) was measured. Absorbance at 700 nm was also measured as an internal control. Active site titrant DDAO-2FGlc 1 was added to a final concentration of 70 µM. The change in absorbance or fluorescence response was monitored. The final change in absorbance was calculated as follows:
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